CRISPR activation to characterize splice-altering variants in easily accessible cells

Tissue-specific gene expression is a major challenge in transcriptome-based rare-disease diagnostics. CRISPR activation is a recently developed tool to activate the expression of genes of interest in vitro. Here, we apply CRISPR activation to clarify the functional impact of splice-altering variants in skin fibroblasts from individuals with neurogenetic diseases.